These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7491183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tc-99m-tetrofosmin scintigraphy: an alternative scintigraphic method for following up differentiated thyroid carcinoma--preliminary results.
    Gallowitsch HJ, Kresnik E, Mikosch P, Pipam W, Gomez I, Lind P.
    Nuklearmedizin; 1996 Dec; 35(6):230-5. PubMed ID: 8976503
    [Abstract] [Full Text] [Related]

  • 5. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P.
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases.
    Nishiyama Y, Yamamoto Y, Ono Y, Takahashi K, Nakano S, Satoh K, Ohkawa M, Tanabe M.
    Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332
    [Abstract] [Full Text] [Related]

  • 7. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
    Bomanji JB, Gacinovic S, Gaze MN, Costa DC, Ell PJ.
    Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706
    [Abstract] [Full Text] [Related]

  • 8. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I.
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [Abstract] [Full Text] [Related]

  • 9. New tracers for the imaging of the medullary thyroid carcinoma.
    Guerra UP, Pizzocaro C, Terzi A, Giubbini R, Maira G, Pagliaini R, Bestagno M.
    Nucl Med Commun; 1989 Apr; 10(4):285-95. PubMed ID: 2544835
    [Abstract] [Full Text] [Related]

  • 10. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
    Kosuda S, Yokoyama H, Katayama M, Yokokawa T, Kusano S, Yamamoto O.
    Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
    Degirmenci B, Aydin A, Comlekci A, Ozdogan O, Bekis R.
    Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid imaging with 99Tcm-tetrofosmin.
    Giordano A, Meduri G, Marozzi P.
    Nucl Med Commun; 1996 Aug; 17(8):706-10. PubMed ID: 8878132
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC, King KL, Yang AH, Liu RS, Yeh SH.
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [Abstract] [Full Text] [Related]

  • 19. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
    Adalet I, Demirkale P, Unal S, Oůz H, Alagöl F, Cantez S.
    Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
    [Abstract] [Full Text] [Related]

  • 20. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC, Sundram FX, Sin AE.
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.